# CoinShares Bitcoin ETF: financial statements, quarterly

BRRR · Nasdaq · CIK 1841175 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/brrr.md) · [Financials](/companies/brrr/financials.md) · [Filings](/companies/brrr/filings.md) · [Insiders](/companies/brrr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/brrr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $m | [0.0](/filings/0001999371-25-006195.md) | [(0.3)](/filings/0001999371-25-011250.md) | [(0.3)](/filings/0001999371-25-017663.md) | [(0.5) d](/filings/0001999371-26-005527.md) | [(0.5)](/filings/0001999371-26-010552.md) | [(0.4)](/filings/0001999371-26-017701.md) | [(0.4)](/filings/0001999371-25-017663.md) | [(0.4) d](/filings/0001999371-26-005527.md) | [(0.3)](/filings/0001999371-26-010552.md) | [(0.3)](/filings/0001999371-26-017701.md) |
| Net income | $m | [90.7](/filings/0001999371-25-006195.md) | [(69.7)](/filings/0001999371-25-011250.md) | [12.6](/filings/0001999371-25-017663.md) | [273 d](/filings/0001999371-26-005527.md) | [(76.6)](/filings/0001999371-26-010552.md) | [141](/filings/0001999371-26-017701.md) | [43.3](/filings/0001999371-25-017663.md) | [(158) d](/filings/0001999371-26-005527.md) | [(121)](/filings/0001999371-26-010552.md) | [(54.7)](/filings/0001999371-26-017701.md) |
| Basic EPS | $ per share | [7.40](/filings/0001999371-25-006195.md) | [(2.43)](/filings/0001999371-25-011250.md) | [0.41](/filings/0001999371-25-017663.md) | not reported | [(2.73)](/filings/0001999371-26-010552.md) | [6.73](/filings/0001999371-26-017701.md) | [2.08](/filings/0001999371-25-017663.md) | not reported | [(5.59)](/filings/0001999371-26-010552.md) | [(2.51)](/filings/0001999371-26-017701.md) |

- Operating income: us-gaap:OperatingIncomeLoss
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-20) | FY2024 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.0](/filings/0001999371-24-004051.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | not reported | [0.0](/filings/0001999371-25-003309.md) | [549](/filings/0001999371-24-006073.md) | [518](/filings/0001999371-24-009824.md) | [570](/filings/0001999371-24-014542.md) | [826](/filings/0001999371-26-005527.md) | [491](/filings/0001999371-25-006195.md) | [626](/filings/0001999371-25-011250.md) | [683](/filings/0001999371-25-017663.md) | [505](/filings/0001999371-26-017701.md) | [430](/filings/0001999371-26-010552.md) | [342](/filings/0001999371-26-017701.md) |
| Total liabilities | $m | not reported | [0.0](/filings/0001999371-25-003309.md) | [6.0](/filings/0001999371-24-006073.md) | [0.1](/filings/0001999371-24-009824.md) | [0.1](/filings/0001999371-24-014542.md) | [0.2](/filings/0001999371-26-005527.md) | [10.6](/filings/0001999371-25-006195.md) | [0.1](/filings/0001999371-25-011250.md) | [0.1](/filings/0001999371-25-017663.md) | [0.1](/filings/0001999371-26-017701.md) | [0.1](/filings/0001999371-26-010552.md) | [0.1](/filings/0001999371-26-017701.md) |
| Shareholders' equity | $m | [0.0](/filings/0001999371-25-003309.md) | [0.0](/filings/0001999371-24-004051.md) | [543](/filings/0001999371-25-011250.md) | [518](/filings/0001999371-25-017663.md) | [570](/filings/0001999371-25-017663.md) | [826](/filings/0001999371-26-017701.md) | [480](/filings/0001999371-26-017701.md) | [626](/filings/0001999371-26-017701.md) | [682](/filings/0001999371-25-017663.md) | [505](/filings/0001999371-26-017701.md) | [430](/filings/0001999371-26-017701.md) | [342](/filings/0001999371-26-017701.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 20,895,000 at 2026-07-30, from the cover of the [10-Q filed 2026-08-12](/filings/0001999371-26-017701.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.